Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas

Maud Toulmonde, Nicolas Penel, Julien Adam, +12

JAMA Oncology

Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study

Maud Toulmonde, Marina Pulido, Isabelle Ray‐Coquard, +20

The Lancet Oncology

OncologyCombination ChemotherapyMetronomic TherapyProgressive Desmoid TumoursPharmacotherapy +6

Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: Formal consensus method for the development of guidelines for standardised time-to-event endpoints’ definitions in cancer clinical trials

Carine Bellera, Marina Pulido, Sophie Gourgou, +13

European Journal of Cancer

Time-to-event EndpointsClinical Trial DesignOncologyMedicineCancer Management +12

Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study

F. Bonichon, Jean Palussière, Yann Godbert, +9

European Journal of Nuclear Medicine and Molecular Imaging

Positron Emission Tomography18F-fdg Pet/ctNuclear MedicineLung MetastasesMedical Imaging +8

Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer

Marina Pulido, Guilhem Roubaud, Anne‐Laure Cazeau, +9

BMC Cancer

Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer

Nathalie Quénel-Tueux, Marc Debled, Justine Rudewicz, +18

British Journal of Cancer

Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials

Florence Lerebours, Marina Pulido, Emmanuelle Fourme, +17

British Journal of Cancer

How to Deal with Interval-Censored Data Practically while Assessing the Progression-Free Survival: A Step-by-Step Guide Using SAS and R Software

Audrey Emmanuelle Dugué, Marina Pulido, Sylvie Chabaud, +2

Clinical Cancer Research

Progression-free SurvivalDisease ProgressionCancer ManagementPrognosisCancer Registration +14

Enhancing Abiraterone Acetate Efficacy in Androgen Receptor–positive Triple-negative Breast Cancer: Chk1 as a Potential Target

Thomas Grellety, Céline Callens, Élodie Richard, +8

Clinical Cancer Research

Role of DNA Repair Gene Polymorphisms in the Efficiency of Platinum-Based Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

Juliette Mathiaux, Valérie Le Morvan, Marina Pulido, +3

Molecular Diagnosis & Therapy

Genome InstabilityPlatinum-based Adjuvant ChemotherapyMedicineGeneticsPathology +8